Literature DB >> 6860610

An automated statis perimeter/adaptometer using light emitting diodes.

W Ernst, D J Faulkner, C R Hogg, D J Powell, G B Arden.   

Abstract

An automated static perimeter/adaptometer is described which measures thresholds with lights of 2 wavelengths. The instrument uses light-emitting diodes to produce the stimuli and is controlled by a small computer, making it very suitable for clinical testing of large numbers of patients. The use of 2 LEDs with different peak emission wavelengths (530 and 660 nm) permits an assessment of the relative state of rod and cone mechanisms in a particular region of the retina either during dark adaptation or when the eye is fully dark adapted.

Entities:  

Mesh:

Year:  1983        PMID: 6860610      PMCID: PMC1040091          DOI: 10.1136/bjo.67.7.431

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Rod and cone vision in retinitis pigmentosa.

Authors:  G WALD; B H ZEAVIN
Journal:  Am J Ophthalmol       Date:  1956-10       Impact factor: 5.258

2.  Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.

Authors:  R W Massof; D Finkelstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-03       Impact factor: 4.799

3.  Peripheral absolute threshold spectral sensitivity in retinitis pigmentosa.

Authors:  R W Massof; M A Johnson; D Finkelstein
Journal:  Br J Ophthalmol       Date:  1981-02       Impact factor: 4.638

4.  Two forms of autosomal dominant primary retinitis pigmentosa.

Authors:  R W Massof; D Finkelstein
Journal:  Doc Ophthalmol       Date:  1981-11       Impact factor: 2.379

  4 in total
  11 in total

1.  A computer-controlled system for measuring dark adaptation and other psychophysical functions.

Authors:  C Friedburg; L T Sharpe; S Beuel; E Zrenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

2.  A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa.

Authors:  A L Lyness; W Ernst; M P Quinlan; G M Clover; G B Arden; R M Carter; A C Bird; J A Parker
Journal:  Br J Ophthalmol       Date:  1985-05       Impact factor: 4.638

3.  Ocular changes in patients undergoing long-term desferrioxamine treatment.

Authors:  G B Arden; B Wonke; C Kennedy; E R Huehns
Journal:  Br J Ophthalmol       Date:  1984-12       Impact factor: 4.638

4.  Vitamin A treatment for night blindness in primary biliary cirrhosis.

Authors:  R P Walt; C M Kemp; L Lyness; A C Bird; S Sherlock
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

5.  Rod and cone psychophysics and electroretinography: methods for comparison in retinal degenerations.

Authors:  K Yagasaki; S G Jacobson; P P Apáthy; R W Knighton
Journal:  Doc Ophthalmol       Date:  1988-06       Impact factor: 2.379

6.  Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study.

Authors:  A T Moore; F Fitzke; M Jay; G B Arden; C F Inglehearn; T J Keen; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

7.  Abnormal dark adaptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation.

Authors:  A T Moore; F W Fitzke; C M Kemp; G B Arden; T J Keen; C F Inglehearn; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

8.  A new cause for difficulty in seeing at night.

Authors:  G B Arden; C R Hogg
Journal:  Doc Ophthalmol       Date:  1985-08-30       Impact factor: 2.379

9.  Rod-cone interactions and analysis of retinal disease.

Authors:  G B Arden; C R Hogg
Journal:  Br J Ophthalmol       Date:  1985-06       Impact factor: 4.638

10.  Ocular findings associated with a 3 base pair deletion in the peripherin-RDS gene in autosomal dominant retinitis pigmentosa.

Authors:  J J Wroblewski; J A Wells; A Eckstein; F W Fitzke; C Jubb; T J Keen; C F Inglehearn; S S Bhattacharya; G B Arden; M R Jay
Journal:  Br J Ophthalmol       Date:  1994-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.